IOPtima is a rapidly growing company focused on developing minimally invasive and innovative surgical ophthalmic devices. Its flagship product, the IOPtimate, is a surgical system for the treatment of glaucoma that utilizes CO2 laser technology to significantly reduce internal eye pressure without penetrating the eye. The company also offers a line of patented eye drops to treat ocular surface diseases.
IOPtima is a Kanghong Pharmaceutical company.
Cumulative Funding Raised Over Time ($)
Employees Over Time
IOPtima Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 27, 2018
www.calcalistech.com
Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company
#Investment #Acquisition
Nov 21, 2017
en.globes.co.il
Chengdu Kanghong Pharma buys Israel's IOPtima for $56m